The effects of Allelock® on treatment of patients with seasonal grass pollinosis

Practica Oto-Rhino-Laryngologica

Volumn 95, Issue 6, 2002, Pages 647-652

  Ohta, Nobuo ^a   Kasajima, Naoko ^a   Aoyagi, Masaru ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Allelock ; ECP; Seasonal grass pollinosis; VEGF

Indexed keywords

ANTIHISTAMINIC AGENT; EOSINOPHIL CATIONIC PROTEIN; OLOPATADINE; VASCULOTROPIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; DRUG USE; GRASS POLLEN; HUMAN; POLLEN ALLERGY; SCORING SYSTEM; SEASONAL VARIATION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0036445606     PISSN: 00326313     EISSN: None     Source Type: Journal    
DOI: 10.5631/jibirin.95.647     Document Type: Article

References (18)

1. Bernardini R, Novembre E, Mugnaini L, et al.: Eosinophil cationic protein (ECP) and tryptase in the nasal lavage fluid (NLF) of children with grass pollen rhinitis. Allergy Asthma Proc 19: 75-80, 1998.
2. Nielsen LP, Bjerke T, Christensen MB, et al.: Eosinophil markers in seasonal allergic rhinitis. Allergy 53: 778-785, 1998.
3. Beppu T, Ohta N, Gonn S, et al.: Eosinophil and eosinophil cationic protein in allergic rhinitis. Acta Otolaryngol (Stockh) 511: 221-223, 1994.
4. Demoly P, Maly PE, Mautino G, et al.: VEGF levels in asthmatic airways do not correlate wth plasma extravasation. Clin Exp Allergy 29: 1390-1394, 1999.
5. Ito A, Hirota S, Mizuno H, et al.: Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cell; possible involvement in the development of edema in chronic inflammation. Pathol Internal 45: 715-720, 1995.
6. Yamashita T, Terada N, Hamano N, et al.: Involvement of vascular endothelial growth factor in nasal obstruction in patients with nasal allergy. Allergol International 49: 183-188, 2000.
7. Ikemura T, Manabe H, Sasaki Y, et al.: KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils. Int Arch Allergy Immunol 110: 57-63, 1996.
8. Miyake K, Ohmori K, Ishii A, et al.: Inhibitory effect of olopatadine hydrochloride (KW-4679), a novel antiallergic drug, on peptide leukotriene release from human eosinophils. Allergol International 50: 113-116, 2001.
9. Ishii H, Kitamura S and Ohmori K: Inhibition of antigen-induced late asthmatic response and airway inflammation by KW-4679. Jpn J Pharmacol 61: 228, 1993.
10. Ikemura T, Okamura K, Sasaki Y, et al.: KW-4679-induced inhibition of tachykininergic contraction in the guinea pig bronchi by prejunctional inhibition of peripheral sensory nerves. Br J Pharmacol 117: 967-973, 1996.
11. Ikemura T, Sasaki Y, Ishii H, et al.: Inhibitory effect of KW-4679 on tachykinin-mediated airway response induced by electrical vagal stimulation in guinea pig. Jpn J Pharmacol 71: 179-182, 1996.